These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15521223)

  • 1. Is salt restriction more important than the length of dialysis in the miracle of Tassin?
    Shaldon S
    Int J Artif Organs; 2004 Sep; 27(9):813-4; author reply 815. PubMed ID: 15521223
    [No Abstract]   [Full Text] [Related]  

  • 2. Salt restriction and not length of dialysis is the key to drug free blood pressure control in ESRD patients.
    Shaldon S
    J Nephrol; 2003; 16(1):159. PubMed ID: 12649549
    [No Abstract]   [Full Text] [Related]  

  • 3. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients.
    Krautzig S; Janssen U; Koch KM; Granolleras C; Shaldon S
    Nephrol Dial Transplant; 1998 Mar; 13(3):552-3. PubMed ID: 9550625
    [No Abstract]   [Full Text] [Related]  

  • 4. Long thrice weekly hemodialysis: the Tassin experience.
    Charra B; Terrat JC; Vanel T; Chazot C; Jean G; Hurot JM; Lorriaux C
    Int J Artif Organs; 2004 Apr; 27(4):265-83. PubMed ID: 15163061
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond the current paradigm: recent advances in the understanding of sodium handling. An introduction.
    Shaldon S; Vienken J
    Semin Dial; 2009; 22(3):252. PubMed ID: 19573003
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment options to intensify hemodialysis.
    Haag-Weber M
    Kidney Blood Press Res; 2003; 26(2):90-5. PubMed ID: 12771532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and treatment of hypertension in dialysis: the case for salt restriction.
    Sanders PW
    Semin Dial; 2007; 20(5):408-11. PubMed ID: 17897246
    [No Abstract]   [Full Text] [Related]  

  • 8. From adequate to optimal dialysis long 3 x 8 hr dialysis: a reasonable compromise.
    Charra B
    Nefrologia; 2005; 25 Suppl 2():19-24. PubMed ID: 16050397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long forgotten salt factor and the benefits of using a 5-g-salt-restricted diet in all ESRD patients.
    Shaldon S; Vienken J
    Nephrol Dial Transplant; 2008 Jul; 23(7):2118-20. PubMed ID: 18403433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Low sodium diet for dialysis patients: myth or reality?].
    Chazot C; Collonge C; Charra B
    Nephrol Ther; 2007 Sep; 3 Suppl 2():S137-40. PubMed ID: 17939970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative outcome studies in end-stage renal disease: how dark are the storm clouds? The salt factor.
    Shaldon S
    Nephrol Dial Transplant; 2008 May; 23(5):1779; author reply 1779-80. PubMed ID: 18281314
    [No Abstract]   [Full Text] [Related]  

  • 12. An explanation for the "lag phenomenon" in drug-free control of hypertension by dietary salt restriction in patients with chronic kidney disease on hemodialysis.
    Shaldon S
    Clin Nephrol; 2006 Jul; 66(1):1-2. PubMed ID: 16878428
    [No Abstract]   [Full Text] [Related]  

  • 13. Once-weekly hemodialysis combined with low-protein and low-salt dietary treatment as a favorable therapeutic modality for selected patients with end-stage renal failure: a prospective observational study in Japanese patients.
    Nakao T; Kanazawa Y; Takahashi T
    BMC Nephrol; 2018 Jun; 19(1):151. PubMed ID: 29954331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to successfully achieve salt restriction in dialysis patients? What are the outcomes?
    Ok E
    Blood Purif; 2010; 29(2):102-4. PubMed ID: 20093812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt and hypertension in end-stage renal disease.
    Shaldon S
    Blood Purif; 2000; 18(1):59. PubMed ID: 10686444
    [No Abstract]   [Full Text] [Related]  

  • 16. Long, slow dialysis.
    Charra B; Chazot C; Jean G; Laurent G
    Miner Electrolyte Metab; 1999; 25(4-6):391-6. PubMed ID: 10681672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction.
    Blumberg A; Nelp WB; Hegstrom RM; Scribner BH
    Lancet; 1967 Jul; 2(7506):69-73. PubMed ID: 4165465
    [No Abstract]   [Full Text] [Related]  

  • 18. [Conservative therapy for chronic renal failure].
    Filipenko PS; Moiseenkova NN
    Klin Med (Mosk); 2004; 82(12):9-15. PubMed ID: 15732711
    [No Abstract]   [Full Text] [Related]  

  • 19. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis.
    Kayikcioglu M; Tumuklu M; Ozkahya M; Ozdogan O; Asci G; Duman S; Toz H; Can LH; Basci A; Ok E
    Nephrol Dial Transplant; 2009 Mar; 24(3):956-62. PubMed ID: 19004849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of the residual renal function in hemodialysis patients].
    Rodríguez Benítez P; Gómez Campderá FJ
    Nefrologia; 2002; 22(2):98-103. PubMed ID: 12085429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.